Navigation Links
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth

, Shire will present the highlights of new data from an exploratory study for VYVANSE as adjunctive therapy in adults with significant cognitive impairments with partially or fully remitted MDD. This study met its primary and secondary endpoints.


  • A Phase 3 clinical trial program to assess the efficacy and safety of VYVANSE as adjunctive therapy in patients with MDD has been initiated.


Mr Patrick Langlois, who has been a member of Shire's Board of Directors for 6 years, will be stepping down from the Board and from the Company's Audit, Compliance & Risk Committee and its Remuneration Committee on the expiry of his current term of office on November 10, 2011. Matthew Emmens, Chairman of Shire, said "We thank Patrick for his contribution to Shire over the past few years".


The following additional information is included in this press release:

Page Overview of Third Quarter 2011 Financial Results 6 Financial Information 10 Non GAAP Reconciliations 19 Safe Harbor Statement 23 Explanation of Non GAAP Measures 24 Trademarks 25


1.    Product sales

For the three months to September 30, 2011 product sales increased by 28% to $1,018.4 million (Q3 2010: $794.3 million) and represented 94% of total revenues (Q3 2010: 91%).

Product Highlights

US Exit Market Year on year growth Share(1) Sales $M Sales CER US Rx(1) Product VYVANSE 199.7 +32% +32% +20% 16% ADDERALL XR 149.9 +50% +50% +8% 7% REPLAGAL 129.0 +40% +31% n/a(3) n/a(3) ELAPRASE(R) 109.6 +13% +7% n/a(2) n/a(2) LIALDA/MEZAVANT(R) 89.7 +18% +17% +7% 21% VPRIV 64.6 +31% +27% n/a(2) n/a(2) INTUNIV(R) 56.1 +50% +50% +59% 4% PENTASA(R) 55.9 -2% -2% -4% 15% DERMAGRAFT 50.0 n/a n/a n/a(2) n/a(2) FOSRENOL(R) 40.5 -10% -14% -17% 5% FIRAZYR 7.2 +148% +129% n/a(2) n/a(2) RESOL

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), ... promotion of Nick Maroulis, Pharm.D. to the newly created ... , In this position, Dr. Maroulis will continue to ... directors of our multi-site pharmacies as the company expands. ... during that time he has served in many different ...
(Date:12/19/2014)... REDWOOD CITY, Calif. , Dec. 19, 2014 ... , USA) announced today that they have been ... Technologies 1,2 is a privately held company that ... processing of next generation sequencing (NGS) data for the ... into the Roche Sequencing Unit, and will continue to ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... 23, 2011 Genesis Biopharma, Inc. (OTC.BB:GNBP), a biotechnology ... California Governor, Gray Davis, has joined the company as ... committed to the improvement of healthcare and advancement of ... California became a leader in stem cell research as ...
... Syngenta announced today that it plans to construct a ... research campus in Research Triangle Park, North Carolina. The ... June 2011, will focus on discovering and developing new ... the world.   "This investment demonstrates ...
... May 20, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... ThinkEquity Annual Healthcare Conference in New York City, NY ... Annual Global Healthcare Conference in Rancho Palos Verdes, CA on June ... presentations will be webcast live and available for replay from Dendreon,s ...
Cached Biology Technology:Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board 2Syngenta to Invest in New U.S. Genetics Research Facility 2
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ... toxicology studies has evolved from short ECG strips ...
(Date:12/10/2014)... --Research and Markets ( ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... the new research results of the VTT Technical Research Centre ... of high-quality biofuels for the price of less than one ... the transfer of more than half the energy of wood ... for the construction of a commercial-scale production plant in Europe. ...
... Amsterdam, July 3, 2013 - Elsevier, a world-leading provider ... today announced the publication of a recent retrospective study ... better understand treatment considerations and outcomes for same-sex male ... The number of same-sex male couples and single ...
... has produced a potential new antibiotic which could help ... The potential new antibiotic targets a bacterial enzyme critical ... inhibitor which binds to the enzyme (called biotin protein ... of the bacteria. "Existing antibiotics target the bacterial ...
Cached Biology News:Gasification method turns forest residues to biofuel with less than a euro per liter 2Reproductive BioMedicine Online publishes study on assisted reproduction 2Novel chemistry for new class of antibiotic 2
... Series Multimode Detectors provide unmatched value ... application and automation needs. Capable of ... on the same instrument, the DTX ... or can be integrated seamlessly with ...
... Solution is available in a ready-to-use ... reagent for dewaxing paraffin-embedded tissue sections ... hybridization, or other analytical methods. The ... of dipping the slides in a ...
... The MJ Mini thermal cycler is a compact ... x 0.2 ml tubes, 12 x 0.5 ml ... heated lid uses a thumbwheel to adjust height ... oil-free cycling. Peltier heat pumps provide excellent thermal ...
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 25x0.2ml tubes...
Biology Products: